Intravenous Administration of Zoledronate in Children with Bone-Associated Langerhans Cell Histiocytosis
-
By
-
Sy, Jann Adriel
-
Quah, Thuan Chong
-
Tee, Pian Pian
-
Ho, Cindy Wei Li
-
April 15, 2026
-
0 min
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
St. Jude Children's Research Hospital
Memphis, TN
Key Differentiators
- Pediatric Hematology-Oncology
- Bone Disease
- Rare Pediatric Disorders
-
#2
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Boston, MA
Key Differentiators
- Pediatric Hematology-Oncology
- Bone Metabolism
- Histiocytosis
-
#3
National University Hospital
Singapore, Singapore
Key Differentiators
- Pediatric Hematology-Oncology
- Bone Disease
- Histiocytosis
-
#4
Memorial Sloan Kettering Cancer Center
New York, NY
Key Differentiators
- Pediatric Hematology-Oncology
- Bone Disease
- Rare Cancers
-
#5
Great Ormond Street Hospital for Children
London, England
Key Differentiators
- Pediatric Hematology-Oncology
- Bone Disorders
- Rare Pediatric Diseases
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.